Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Do you really want to delete this prezi?
Neither you, nor the coeditors you shared it with will be able to recover it again.
Make your likes visible on Facebook?
Connect your Facebook account to Prezi and let your likes appear on your timeline.
You can change this under Settings & Account at any time.
Transcript of Theobromine
<the compound of chocolate>
Quyen Anh Pham
All routes, but mostly oral administration
Bioavailability 96% in humans
Peak plasma concentration at 2.5 hours
90% unbound in plasma
Potential to cross BBB
Demethylation at 1, 3, 7 positions by CYP450
Broken down into metabolites 3-methylxanthine and 7-methylxanthine
7-methylxanthine to 7-methyluric acid by xanthine oxidase
Less than 10% through GI tract
Water soluble (logP=-0.69)
Small size (0.18kDa) so mostly freely filtered in glomerulus
Volume of Distribution = 0.62 L/kg
pKa=10 (ionized form in stomach and intestines)
G-coupled protein receptor
Natural, competitive, nonselective antagonist at A1 and A2
Main target is heart
Weakly affects CNS
Decreased thymus weight, heart rate, excitability, growth
1-1.5% administered orally for 120 days = Dead
Forensics for an Overdose
Chromatographic methods, such as thin-layer chromatography, high-performance liquid chromatography, and capillary electrophoresis
UV spectroscopy with a separation procedure
Modern Societal Use
Potential Medical and Other Uses
Pest Coyote Control
Potential Medical & Health Uses
Adamafio, N. (2013). "Theobromine Toxicity and Remediation of Cocoa By-products: An Overview." Journal of Biological Sciences 13(7).
Agudelo, C., et al. (2013). "Chocolate ingestion-induced non-cardiogenic pulmonary oedema in a puppy: a case report." Veterinarni Medicina 58(2).
Arnaud M.J. and C. Welsch (1979). “Theophylline and caffeine metabolism in man.” Methods in Clinical Pharmacology 3:135-148.
Baggott, M. J., et al. (2013). "Psychopharmacology of theobromine in healthy volunteers." Psychopharmacology 228(1): 109-118.
Berkowitz, B.A., S. Spector, and W. Pool (1971). “The interaction of caffeine, theophylline and theobromine with monoamine oxidase inhibitors.” European Journal of Pharmacology 16(3): 315-321.
Bibra, E. and J. Ott (1995). Plant Intoxicants: A Classic Text on the Use of Mind-altering Plants.
Bonati, M. R. Latini, B. Sadurska, E. Riva, F. Galletti, J.F. Borzelleca, S.M. Tarka, M.J. Arnaud and S. Garattini (1984). “Kinetics and metabolism of theobromine in male rats.” Toxicology 30(4): 327-341.
Chou C.C. and T.W. Vickroy (2003). “Antagonism of adenosine receptors by caffeine and caffeine metabolites in equine forebrain tissues.” Am J Vet Res 64: 216–224.
Dyke, T. and R. Sams (1998). "Detection and determination of theobromine and caffeine in urine after administration of chocolate-coated peanuts to horses." Journal of analytical toxicology 22(2): 112-116.
Fredholm, B.B. (2010). “Adenosine receptors as drug targets.” Experimental Cell Research 316(8): 1284-1288.
Hurst, W.J., R.A. Martin and S.M. Tarka (1984). “Analytical methods for quantitation of methylxanthines.” Prog Clin Biol Res 158:17-28.
Johnston, J. J. (2005). "Evaluation of cocoa-and coffee-derived methylxanthines as toxicants for the control of pest coyotes." Journal of agricultural and food chemistry 53(10): 4069-4075.
Machata, S.G. and S.H. Yalkowsky (2005). “Comparison of the octanol/water partition coefficients calculated by ClogP, ACDlogP and KowWin to experimentally determined values.” International Journal of Pharmaceutics 294(1): 185-192.
Miller G.E. et al. (1984). “Comparative theobromine metabolism in five mammalian species.” Drug Metabolism and Disposition 12(2):154-160.
Patel, V., et al. (2012). "Chocolates as Dosages form-An Overview." Int. J. of Pharm. & Research Sci.(IJPRS) 1(6): 397-412.
Pu, Q.S. and Z.L. Fang (1999). “Combination of flow injection with capillary electrophoresis. Part 6.: A bias-free sample introduction system based on electroosmotic-flow traction.” Analytica Chimica Acta 398(1): 65-74.
Ramli, N. et al (2000). "Caffeine and Theobromine Levels in Chocolate Couverture and Coating Products." Malaysian Journal of Nutrition 6: 55-63.
Reddy, B. S., et al. (2013). "Chocolate Poisoning in a Dog." International Journal of Veterinary Health Science & Research 1(4): 1-3.
Resman, B.H. et al. (1977). “Breast milk distribution of theobromine from chocolate.” The Journal of Pediatrics 91(3): 477-480.
Smit, H.J. (2011). “Theobromine and the Pharmacology of Cocoa.” Methylxanthines 200: 201-234.
Stavric, B. (1988). "Methylxanthines: toxicity to humans. 3. Theobromine, paraxanthine and the combined effects of methylxanthines." Food and chemical toxicology 26(8): 725-733.
Timson, J. (1975). "Theobromine and theophylline." Mutation Research/Reviews in Genetic Toxicology 32(2): 169-177.
Wilkinson, J.M. and I. Pollard (1993). “Accumulation of theophylline, theobromine, and paraxanthine in the fetal rat brain following a single oral dose of caffeine.” Brain Res Dev Brain Res 75(2): 193-199.
Yesair, D.W., A.R. Branfman, and M.M. Callahan (1984). “Human disposition and some biochemical aspects of methylxanthines.” Prog Clin Biol Res 158: 215-233.
Zhang, H.M. et al. (2009). “Binding of caffeine, theophylline, and theobromine with human serum albumin: A spectroscopic study.” Journal of Molecular Structure 938(1-3): 221-228.
Metabolite of caffeine
Comes from plants
Found in chocolate
TOXICITY IN HUMANS
Little to no accurate data on TD50 or lethality in humans
1000mg (5 dark chocolate bars) reported:
Decreased alertness & responsiveness
Headaches, nausea, vomiting
Extrapolation of toxic dose of a rat = 18g/day in humans
171 milk chocolate bars or 90 dark chocolate bars!!!
300-600mg recommended for cardiac stimulation, diuresis, & arterial dilation
Compared to humans, theobromine is:
Metabolized in liver slower
Undergoes enteroheptatic recycling
Excreted with parent compounds & metabolites
Half-life = 17.5hrs
TOXICITY IN DOGS:
More to less toxic: Cooking chocolate/Cocoa powder > Dark > Milk
Oral LD50 = 100-500mg/kg
restlessness / over-stimulation, hyperacidity, vomiting, diarrhea, stiffness, muscle twitching, rapid breathing, seizures
Death caused by irregular heartbeats, hyperthermia, respiratory failure, edema, congestion
20mg/kg for cardiac stimulation & diuresis
BUT reports of toxic effects at this dose (restlessness & vomiting)
ED50 not extensively researched
Increased #dead pups/litter
More abnormal sperm, smaller testicles, changes in Sertoli cells
oral LD50 = 950mg/kg
Theobromine mix as a more socially acceptable form to control coyotes and reduce loss of cattle and calves for farmers
Considered as a
in equine sports to alter/enhance racehorse performance
Vascular dysfunction & inflammatory diseases
Restricted cardiac blood flow
Dental plaque prevention
Methylxanthine similar to caffeine
Most usually found in chocolate
Oral administration, 96% bioavailability, excreted in urine
Very water soluble
Competitive Antagonist of G-coupled Adenosine receptors
Not lethal in humans, but very toxic to dogs and other animals
Methylxanthine known as theophylline
Targets the same adenosine receptors
Increases the toxicological potential of Theobromine when taken together
Additive metabolite effect
Monoamine oxidase inhibitor
High blood pressure drug
Lowers the LD50 of Theobromine by 50%
Increasing the toxicity
Reversed the typical effects of Theobromine, resulting in agitation, disorientation, and hyperthermia